BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 30565137)

  • 1. CRISPR-Mediated Approaches to Regulate YAP/TAZ Levels.
    Quinton RJ; Ganem NJ
    Methods Mol Biol; 2019; 1893():203-214. PubMed ID: 30565136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo signalling during development.
    Davis JR; Tapon N
    Development; 2019 Sep; 146(18):. PubMed ID: 31527062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAPping about and not forgetting TAZ.
    Callus BA; Finch-Edmondson ML; Fletcher S; Wilton SD
    FEBS Lett; 2019 Feb; 593(3):253-276. PubMed ID: 30570758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the Phosphorylation Status of Hippo Components YAP and TAZ Using Phos-tag.
    Chen R; Plouffe SW; Guan KL
    Methods Mol Biol; 2019; 1893():281-287. PubMed ID: 30565141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Self-Deleting AAV-CRISPR System for
    Li A; Lee CM; Hurley AE; Jarrett KE; De Giorgi M; Lu W; Balderrama KS; Doerfler AM; Deshmukh H; Ray A; Bao G; Lagor WR
    Mol Ther Methods Clin Dev; 2019 Mar; 12():111-122. PubMed ID: 30619914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction.
    Bum-Erdene K; Zhou D; Gonzalez-Gutierrez G; Ghozayel MK; Si Y; Xu D; Shannon HE; Bailey BJ; Corson TW; Pollok KE; Wells CD; Meroueh SO
    Cell Chem Biol; 2019 Mar; 26(3):378-389.e13. PubMed ID: 30581134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippo Pathway: Biology and Pathophysiology.
    Ma S; Meng Z; Chen R; Guan KL
    Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and Biochemical Analyses of the Core Components of the Hippo Pathway.
    Ni L; Luo X
    Methods Mol Biol; 2019; 1893():239-256. PubMed ID: 30565138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear TAZ activity distinctly associates with subtypes of non-small cell lung cancer.
    Wang Y; Han Y; Guo Z; Yang Y; Ren T
    Biochem Biophys Res Commun; 2019 Feb; 509(3):828-832. PubMed ID: 30638934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer.
    Sarmasti Emami S; Ge A; Zhang D; Hao Y; Ling M; Rubino R; Nicol CJB; Wang W; Yang X
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From static to dynamic: The influence of mechanotransduction on skin equivalents analyzed by bioimaging and RNAseq.
    Kaiser K; Bendixen SM; Sørensen JA; Brewer JR
    Mater Today Bio; 2024 Apr; 25():101010. PubMed ID: 38495916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human ovarian tissue manipulation on follicles: evidence of a potential first wave of follicle activation during fertility preservation procedures.
    Barretta M; Cacciottola L; Hossay C; Donnez J; Dolmans MM
    J Assist Reprod Genet; 2023 Dec; 40(12):2769-2776. PubMed ID: 37713145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
    Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
    FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo Pathway Regulation by Tyrosine Kinases.
    Reuven N; Shanzer M; Shaul Y
    Methods Mol Biol; 2019; 1893():215-236. PubMed ID: 30565137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the Hippo Pathway Transcription Factor TEAD.
    Lin KC; Park HW; Guan KL
    Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP and WWTR1: New targets for skin cancer treatment.
    Andl T; Zhou L; Yang K; Kadekaro AL; Zhang Y
    Cancer Lett; 2017 Jun; 396():30-41. PubMed ID: 28279717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of the mammalian Hippo signaling pathway.
    Ji XY; Zhong G; Zhao B
    Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
    Zhao B; Lei QY; Guan KL
    Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.